TPX2 promotes osteosarcoma progression by conferring ferroptosis resistance through the AURKA/NRF2 signaling axis

Huashun Liu, Lan Tang, Biao Chen, Jingtao Yu

Open source

DOI
10.1016/j.jbo.2026.100807
Published
2026-12
Container
Journal of Bone Oncology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jbo.2026.100807,
  title = {TPX2 promotes osteosarcoma progression by conferring ferroptosis resistance through the AURKA/NRF2 signaling axis},
  author = {Huashun Liu and Lan Tang and Biao Chen and Jingtao Yu},
  year = {2026},
  journal = {Journal of Bone Oncology},
  doi = {10.1016/j.jbo.2026.100807},
  url = {https://doi.org/10.1016/j.jbo.2026.100807}
}

RIS

TY  - JOUR
TI  - TPX2 promotes osteosarcoma progression by conferring ferroptosis resistance through the AURKA/NRF2 signaling axis
AU  - Huashun Liu
AU  - Lan Tang
AU  - Biao Chen
AU  - Jingtao Yu
PY  - 2026
JO  - Journal of Bone Oncology
DO  - 10.1016/j.jbo.2026.100807
UR  - https://doi.org/10.1016/j.jbo.2026.100807
ER  - 

APA

Liu, H., Tang, L., Chen, B., & Yu, J. (2026). TPX2 promotes osteosarcoma progression by conferring ferroptosis resistance through the AURKA/NRF2 signaling axis. Journal of Bone Oncology. https://doi.org/10.1016/j.jbo.2026.100807

Source records